Coadjuvant Anti-VEGF A Therapy Improves Survival in Patients with Colorectal Cancer with Liver Metastasis: A Systematic Review
Background: the presence of liver metastasis in colorectal cancer (CRC) remains one of the most significant prognostic factors. Objective: systematically review the results of studies evaluating the benefit of adding bevacizumab to a normal chemotherapy regime in the survival of patients with colore...
Main Authors: | Isabel Novo, Bárbara Campos, Filipa Pinto-Ribeiro, Sandra F. Martins |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Gastrointestinal Disorders |
Subjects: | |
Online Access: | https://www.mdpi.com/2624-5647/2/2/7 |
Similar Items
-
VEGF Expression in Colorectal Cancer Metastatic Lymph Nodes: Clinicopathological Correlation and Prognostic Significance
by: Inês Mazeda, et al.
Published: (2020-08-01) -
The Relationship of Smoking and Lymph Node Metastasis with Survival in Colorectal Cancers
by: Sevda Yeşim ÖZDEMİR, et al.
Published: (2022-08-01) -
The Effects of Primary Tumor Location on Survival after Liver Resection for Colorectal Liver Metastasis in the Mediterranean Population
by: Ahmad Mahamid, et al.
Published: (2023-08-01) -
Survival nomograms for simultaneous resection of primary and hepatic lesions without neoadjuvant chemotherapy in patients with resectable colorectal liver metastasis
by: Yu‐Juan Jiang, et al.
Published: (2023-08-01) -
Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer
by: Cai Xiaopeng, et al.
Published: (2012-05-01)